[Event Report] The Meeting of Working Group 1 on Life Course Approach, “The Next Actions to Ensure the Development and Implementation of Immunization and Vaccine Policies” (March 9, 2022)
date : 4/5/2022
Tags: Vaccinations
On March 9, 2022, Health and Global Policy Institute (HGPI) held a meeting of “Next Actions to Ensure the Development and Implementation of Immunization and Vaccine Policies Working Group 1 – The Life Course Approach.”
Among life stages including infancy, early childhood, childhood, puberty, adolescence, adulthood, and old age, Japan’s immunization and vaccination policies have centered on infancy, early childhood, and childhood. These policies have contributed to better health and quality of life for the public. However, as demonstrated by a growing body of global scientific evidence, a life course approach to vaccination which takes every life stage into account not only helps to maintain public health, but also generates socioeconomic benefits. Broader vaccination coverage is also likely to result in better control of communicable diseases and stronger protection of unvaccinated individuals.
At this meeting, we deepened the discussion on issues and next steps for transitioning to a life course approach in immunization and vaccination policies.
To prevent the potential spread of COVID-19, this meeting was held online using a remote conferencing system.
■ 2021 Advisory Board Working Group 1 (Titles omitted; in Japanese alphabetical order by last name)
Members:
- Kyoko Ama (Representative, Children and Healthcare Project)
- Hidenori Arai (President, National Center for Geriatrics and Gerontology; Vice President, The Japan Geriatrics Society)
- Kanako Inaba (Physician, M.D., and specialist in obstetrics and gynecology; Representative, Minpapi! Let’s Learn About HPV Project; Specialist in charge of obstetrics and gynecology, Corowakun Supporters; Vice President, Medical Femtec Consortium, Pro Picker, NewsPicks)
- Satoshi Iwata (Department of Infectious Diseases, National Cancer Center Hospital Visiting Professor, Department of Infectious Diseases, Keio University School of Medicine Chairperson, The Expert Council on Promotion of Vaccination)
- Kazunori Oishi (Chief, Toyama Institute of Health)
- Yoko Katakura (Director, Policy and Public Affairs Department, Policy and Public Affairs Division, Pfizer Japan Inc.)
- Hideaki Nagai (Director, Department of Infectious Diseases, Tokyo National Hospital, National Hospital Organization)
- Daisuke Watanabe (Professor, Department of Dermatology, Aichi Medical University)
MC/Moderator:
- Joji Sugawara (Manager, Health and Global Policy Institute)
■Related contents held as part of the project
– November 4, 2021 The First Meeting of Working Group 5 on Vaccine Research and Development, “Next Actions for the Development and Implementation of Immunization and Vaccination Policies”
– January 17, 2022 The Second Meeting of Working Group 5 on Vaccine Research and Development, “The Next Actions to Ensure the Development and Implementation of Immunization and Vaccine Policies”
Top Research & Recommendations Posts
- [Policy Recommendations] Kidney Disease Control Promotion Project 2023 “Establishing Kidney Disease Control Measures with Patient, Citizen, and Community Engagement and Collaboration” Policy Recommendations, a Collection of Good Practices of Chronic Kidney Disease (CKD) and Control Measures in Local Governments (February 14, 2024)
- [Announcement] A Significant Step Towards the Building a Green Healthcare System: Support for the Formal Expression of Interest by the Japanese Government Delegation to the ATACH at the Executive Board Meeting of the WHO (February 16, 2024)
- [Research Report] Survey of Japanese Physicians Regarding Climate Change and Health (December 3, 2023)
- [Research Paper] “Rethinking Japan’s Health System Sustainability Under the Planetary Health Framework” Published in Health Systems & Reform (November 21, 2023)
- [Research Report] The Public Opinion Survey on Child-Rearing in Modern Japan (Final Report) (March 4, 2022)
- [Research Report] 2019 Survey on Healthcare in Japan
- [Announcement] HGPI Joins Call for “Global Health and Medical Community Unite To Demand End Fossil Fuel Dependency at COP28” (November 1, 2023)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
- [Recommendations] AMR Alliance Japan Delivered Policy Recommendations on AMR to Minister of Health, Labour and Welfare Katsunobu Kato and Minister of Foreign Affairs Yoshimasa Hayashi(November 10, 2022)
- [Publication Report] Developing and Expanding Cardiovascular Disease Control Plans in Each Prefecture – Challenges and Good Examples for Cardiovascular Disease Control (September 7, 2023)
Featured Posts
-
2024-03-04
[Event Report] Non-partisan Diet Member Briefing – 30-minute Health Policy Update: “Issues Surrounding and Necessary Measures Against Obesity Disease” (February 2, 2024)
-
2024-03-04
[Public Comment Submission] Conference of the Parties to the Convention on Biological Diversity “Call for Peer Review of the Draft Global Action Plan on Biodiversity and Health” (February 12, 2024)
-
2024-03-05
[HGPI Policy Column] (No.41) – From the Mental Health Project Team – Mental Health Policy in Japan – History and Future Policy Topics (Part 1 of HGPI Activities for Mental Health and Domestic Policy History)
-
2024-03-08
[Event Report] Online Global Expert Meeting “Global Trends and Japan’s Pain Policy“ (November 16, 2023)
-
2024-03-18
[Registration Open] International Symposium “Promotion of Menopausal Women’s Health as a Social Issue to be Considered by Industry, Government, Academia and the Private Sector” (April 9, 2024)